BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11682143)

  • 21. Narcolepsy and the hypocretins.
    Wurtman RJ
    Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602.
    Black JL; Krahn LE; Pankratz VS; Silber M
    Sleep; 2002 Nov; 25(7):719-23. PubMed ID: 12405606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired histaminergic neurotransmission in children with narcolepsy type 1.
    Franco P; Dauvilliers Y; Inocente CO; Guyon A; Villanueva C; Raverot V; Plancoulaine S; Lin JS
    CNS Neurosci Ther; 2019 Mar; 25(3):386-395. PubMed ID: 30225986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of extracts from St. John's Wort and Kava Kava on brain neurotransmitter levels in the mouse.
    Serdarevic N; Eckert GP; Müller WE
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S134-6. PubMed ID: 11518062
    [No Abstract]   [Full Text] [Related]  

  • 25. Greatly increased numbers of histamine cells in human narcolepsy with cataplexy.
    John J; Thannickal TC; McGregor R; Ramanathan L; Ohtsu H; Nishino S; Sakai N; Yamanaka A; Stone C; Cornford M; Siegel JM
    Ann Neurol; 2013 Dec; 74(6):786-93. PubMed ID: 23821583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain dopamine receptor levels elevated in canine narcolepsy.
    Bowersox SS; Kilduff TS; Faull KF; Zeller-DeAmicis L; Dement WC; Ciaranello RD
    Brain Res; 1987 Jan; 402(1):44-8. PubMed ID: 3828787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.
    Beuckmann CT; Yanagisawa M
    J Mol Med (Berl); 2002 Jun; 80(6):329-42. PubMed ID: 12072908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy.
    Tanaka S; Honda Y; Inoue Y; Honda M
    Sleep; 2006 May; 29(5):633-8. PubMed ID: 16774153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
    Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related changes in histamine receptor mRNA levels in the mouse brain.
    Terao A; Steininger TL; Morairty SR; Kilduff TS
    Neurosci Lett; 2004 Jan; 355(1-2):81-4. PubMed ID: 14729240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models of narcolepsy.
    Chen L; Brown RE; McKenna JT; McCarley RW
    CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):296-308. PubMed ID: 19689311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency?
    Arnulf I; Lin L; Zhang J; Russell IJ; Ripley B; Einen M; Nevsimalova S; Bassetti C; Bourgin P; Nishino S; Mignot E
    Sleep; 2006 Aug; 29(8):1017-24. PubMed ID: 16944669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypocretin administration as a treatment for human narcolepsy.
    Siegel JM
    Sleep; 2003 Dec; 26(8):932-3. PubMed ID: 14746368
    [No Abstract]   [Full Text] [Related]  

  • 34. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Participation of histaminergic H1 and noradrenergic alpha 1 receptors in orexin A-induced wakefulness in rats.
    Shigemoto Y; Fujii Y; Shinomiya K; Kamei C
    Brain Res; 2004 Oct; 1023(1):121-5. PubMed ID: 15364026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in hypocretin/orexin pathway genes and narcolepsy.
    Olafsdóttir BR; Rye DB; Scammell TE; Matheson JK; Stefánsson K; Gulcher JR
    Neurology; 2001 Nov; 57(10):1896-9. PubMed ID: 11723285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of methionine on regional CDF-1 mouse brain monoamines.
    Messiha FS
    Drug Chem Toxicol; 1990; 13(4):355-65. PubMed ID: 2279463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoamine changes in the brain of cats during slow-wave sleep.
    Kovacević R; Radulovacki M
    Science; 1976 Sep; 193(4257):1025-7. PubMed ID: 948760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Narcoleptic dogs. Significance for human narcolepsy].
    Schiefer J
    Nervenarzt; 2003 Dec; 74(12):1155-6. PubMed ID: 14647919
    [No Abstract]   [Full Text] [Related]  

  • 40. What we learned from narcolepsy of others.
    Luft FC
    J Mol Med (Berl); 2003 Feb; 81(2):69-70. PubMed ID: 12675031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.